Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Net Income towards Common Stockholders (2016 - 2025)

Aethlon Medical filings provide 15 years of Net Income towards Common Stockholders readings, the most recent being -$1.9 million for Q1 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 20.63% to -$1.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was -$9.0 million, a 25.81% increase, with the full-year FY2025 number at -$9.1 million, up 25.84% from a year prior.
  • Net Income towards Common Stockholders hit -$1.9 million in Q1 2025 for Aethlon Medical, down from -$1.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.8 million in Q4 2024 to a low of -$3.8 million in Q3 2022.
  • Median Net Income towards Common Stockholders over the past 5 years was -$2.5 million (2021), compared with a mean of -$2.7 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 89.54% in 2022 and later surged 49.37% in 2024.
  • Aethlon Medical's Net Income towards Common Stockholders stood at -$2.5 million in 2021, then decreased by 12.83% to -$2.8 million in 2022, then fell by 21.63% to -$3.5 million in 2023, then soared by 49.37% to -$1.8 million in 2024, then dropped by 8.85% to -$1.9 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$1.9 million (Q1 2025), -$1.8 million (Q4 2024), and -$2.8 million (Q3 2024) per Business Quant data.